NCT05167305

The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease

The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease-A Record Based Cross-Sectional Study.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,316 (actual)
• Sponsor: Institute of Liver and Biliary Sciences, India · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Hospital record of the patients of liver disease admitted from April-May 2021 and April-May 2019 will be reviewed. Patients will be analyzed and compared for the demographic characteristics, severity of liver disease at time of admission and outcome in form of survival or mortality, liver transplantation rates in the two time periods and the subsequent 30 d and 90 day readmission rate. Monitoring and assessment: Hospital records of all patients of liver disease needing admission during the April-May 2019 and 2021, but without active COVID-19 infection, will be reviewed. Patients will be analyzed and compared for the demographic characteristics, severity of liver disease at time of admission and outcome in form of survival or mortality, liver transplantation rates in the two time periods and 30 d and 90 d readmission rate.

Conditions

• Liver Diseases

Interventions

Type	Name	Description
OTHER	This is an observational study	This is an observational study

Timeline

• Start date: 2021-12-22
• Primary completion: 2021-12-31
• Completion: 2021-12-31
• First posted: 2021-12-22
• Last updated: 2022-01-04

Locations

1 site across 1 country: India